Edition:
United Kingdom

Neurotrope Inc (NTRP.OQ)

NTRP.OQ on NASDAQ Stock Exchange Capital Market

8.65USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$8.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,721
52-wk High
$21.31
52-wk Low
$3.41

Select another date:

Fri, Jan 5 2018

BRIEF-Neurotrope's Bryostatin Improves Cognition In Patients

* NEUROTROPE'S BRYOSTATIN IMPROVES COGNITION IN PATIENTS WITH ADVANCED ALZHEIMER'S DISEASE BASED ON FURTHER ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA Source text for Eikon: Further company coverage:

BRIEF-Neurotrope Appoints Charles S. Ryan As CEO

* NEUROTROPE APPOINTS CHARLES S. RYAN AS CHIEF EXECUTIVE OFFICER

Select another date: